Charles Schwab Investment Management Inc Co Diagnostics, Inc. Transaction History

Charles Schwab Investment Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$5.03 - $9.61 $216,159 - $412,980	-42,974 Reduced 79.52%	11,070 $69,000
Q2 2021 Aug 16, 2021	SELL	$7.16 - $9.56 $410,003 - $547,434	-57,263 Reduced 51.45%	54,044 $446,000
Q1 2021 May 17, 2021	BUY	$8.52 - $19.21 $411,788 - $928,457	48,332 Added 76.75%	111,307 $1.06 Million
Q3 2020 Nov 13, 2020	SELL	$8.24 - $30.8 $6,583 - $24,609	-799 Reduced 1.25%	62,975 $856,000
Q2 2020 Aug 14, 2020	BUY	$7.46 - $23.42 $475,754 - $1.49 Million	63,774 New	63,774 $1.24 Million

4.28M

48.2K

53.3K

Ticker CODX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 33,781,000
Market Cap $24.7M
Description
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.